Differentiating vasculitis from other diseases: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 39: | Line 39: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound/ Echocardiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ||
|- | |- | ||
Line 250: | Line 250: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound/ Echocardiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | ||
Line 659: | Line 659: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound/ Echocardiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | ||
Line 667: | Line 667: | ||
! rowspan="33" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis | ! rowspan="33" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis | ||
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]] | ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Microscopic polyangiitis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Microscopic polyangiitis]]<ref name="pmid20688249">{{cite journal| author=Chung SA, Seo P| title=Microscopic polyangiitis. | journal=Rheum Dis Clin North Am | year= 2010 | volume= 36 | issue= 3 | pages= 545-58 | pmid=20688249 | doi=10.1016/j.rdc.2010.04.003 | pmc=2917831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20688249 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 676: | Line 676: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Anti-PR3 | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C-ANCA|Anti-PR3 antibody (C-ANCA)]] (40%), [[P-ANCA|Anti-MPO antibody (P-ANCA)]] (60%) | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normocytic anemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Proteinuria]], [[RBC casts|Erythrocyte casts]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Suspected [[pancreatitis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mesenteric]] [[angiography]] for differentiating from [[polyarteritis nodosa]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bilateral nodular, and patchy [[Opacity|opacities]] in [[Chest X-ray|CXR]] | ||
! | ![[Glomerulonephritis]] with focal [[necrosis]], crescent formation, and lack or paucity of [[immunoglobulin]] deposits | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rash]], [[Hemoptysis]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]]<ref name="pmid27195187">{{cite journal| author=Kubaisi B, Abu Samra K, Foster CS| title=Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. | journal=Intractable Rare Dis Res | year= 2016 | volume= 5 | issue= 2 | pages= 61-9 | pmid=27195187 | doi=10.5582/irdr.2016.01014 | pmc=4869584 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27195187 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
Line 697: | Line 697: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Anti-PR3 | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C-ANCA|Anti-PR3 antibody (C-ANCA)]] (90%), [[P-ANCA|Anti-MPO antibody (P-ANCA)]] (10%) | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normochromic anemia|Normochromic normocytic anemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], [[Hypoalbuminemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Consolidation (medicine)|Consolidation]], Patchy or diffuse [[Ground glass opacification on CT|ground-glass opacities]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Occlusion]] or [[stenosis]] of [[LAD]] and [[RCA]] in [[coronary angiography]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Single or multiple [[nodules]] and [[Mass|masses]] with [[cavitation]] in [[CXR]] | ||
! | ![[Parenchymal]] [[necrosis]], [[Granulomatous]] [[inflammation]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Conjunctivitis]], | ||
[[Episcleritis]], | |||
[[Uveitis]], | |||
[[Optic nerve]] vasculitis | |||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Eosinophilic granulomatosis with polyangiitis|Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Eosinophilic granulomatosis with polyangiitis|Eosinophilic granulomatosis with polyangiitis]] | ||
[[Eosinophilic granulomatosis with polyangiitis|(Churg-Strauss)]]<ref name="pmid16612766">{{cite journal |vauthors=Keogh KA, Specks U |title=Churg-Strauss syndrome |journal=Semin Respir Crit Care Med |volume=27 |issue=2 |pages=148–57 |date=April 2006 |pmid=16612766 |doi=10.1055/s-2006-939518 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 718: | Line 725: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Eotaxin-3 | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[P-ANCA|Anti-MPO antibody (P-ANCA)]] (40%), Eotaxin-3 | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophilia]], [[Anemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], [[Proteinuria]], [[RBC casts|Erythrocyte casts]], ↑[[Immunoglobulin E|IgE]] levels | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Significant enlargement of peripheral [[pulmonary arteries]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Myocardial ischemia]] and [[Myocardial infarction|infarction]] in [[coronary angiography]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Congestive heart failure|Congestive heart failure (CHF)]] in [[echocardiography]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Extensive air-space [[Opacity|opacities]] in [[CXR]] | ||
! | ! Small [[necrotizing]] [[granulomas]] with [[eosinophilic]] core surrounded by [[macrophages]] and [[Epithelioid cell|epithelioid giant cells]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Allergic rhinitis]], [[Asthma]], [[Urticaria|Urticarial rash]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hydralazine]]-associated [[ANCA-associated vasculitis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hydralazine]]-associated [[ANCA-associated vasculitis]]<ref name="pmid23316942">{{cite journal| author=Keasberry J, Frazier J, Isbel NM, Van Eps CL, Oliver K, Mudge DW| title=Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report. | journal=J Med Case Rep | year= 2013 | volume= 7 | issue= | pages= 20 | pmid=23316942 | doi=10.1186/1752-1947-7-20 | pmc=3565908 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23316942 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 739: | Line 746: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[P-ANCA|Anti-MPO antibody (P-ANCA)]], Anti-histone antibodies | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], [[Hypoalbuminemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bilateral [[pulmonary]] infiltrates | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aneurysms]] or [[Occlusion|occlusions]] of the [[Visceral|visceral arteries]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! | !Pauci-immune [[necrotizing]] and [[crescentic glomerulonephritis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Sinusitis]], [[Hemoptysis]] | ||
|- | |- | ||
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis | ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Goodpasture disease|Anti-glomerular basement membrane disease]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Goodpasture disease|Anti-glomerular basement membrane disease]]<ref name="pmid28515156">{{cite journal |vauthors=McAdoo SP, Pusey CD |title=Anti-Glomerular Basement Membrane Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=7 |pages=1162–1172 |date=July 2017 |pmid=28515156 |doi=10.2215/CJN.01380217 |url=}}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 761: | Line 768: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypochromic anemia|Hypochromic microcytic anemia]], [[Thrombocytopenia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓[[C3 (complement)|C3]] level | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary hemorrhage]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal [[kidneys]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Alveolar]] infiltrates spreading from the [[hilum]] in [[CXR]] | ||
! | !Cellular crescents in the [[glomeruli]], [[Pulmonary hemorrhage|Intra-alveolar hemorrhages]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hemoptysis]], [[Hematuria]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cryoglobulinemia|Cryoglobulinemic vasculitis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cryoglobulinemia|Cryoglobulinemic vasculitis]]<ref name="pmid16344620">{{cite journal |vauthors=Ferri C, Mascia MT |title=Cryoglobulinemic vasculitis |journal=Curr Opin Rheumatol |volume=18 |issue=1 |pages=54–63 |date=January 2006 |pmid=16344620 |doi= |url=}}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
Line 783: | Line 790: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C4A|C4 component]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C4A|C4 component]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[hypocomplementemia]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O underlying [[malignancy]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stenosis]] or [[Occlusion|occlusions]] of the [[Visceral|visceral arteries]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bacterial endocarditis]] in [[echocardiography]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Interstitial]] involvement or [[pleural effusions]] in [[CXR]] | ||
! | ![[HCV]]-associated [[proteins]] in [[vasculitic]] [[skin]], Intraluminal [[cryoglobulin]] deposits | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acrocyanosis]], [[Retinal]] [[hemorrhage]], [[Purpura]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]] | ||
Line 1,382: | Line 1,389: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound/ Echocardiography | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology |
Revision as of 20:21, 30 March 2018
Vasculitis |
|
---|
gsEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Differential Diagnosis
Abbreviations: ABG= Arterial blood gas, ANP= Atrial natriuretic peptide, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure.
References
- ↑ Vaideeswar P, Deshpande JR (2013). "Pathology of Takayasu arteritis: A brief review". Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.
- ↑ Calvo-Romero JM (2003). "Giant cell arteritis". Postgrad Med J. 79 (935): 511–5. PMC 1742823. PMID 13679546.
- ↑ Stafa A, Leonardi M (2008). "Role of neuroradiology in evaluating cerebral aneurysms". Interv Neuroradiol. 14 Suppl 1: 23–37. doi:10.1177/15910199080140S106. PMC 3328052. PMID 20557771.
- ↑ Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J (2017). "Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1". Case Rep Ophthalmol. 8 (1): 214–220. doi:10.1159/000469702. PMC 5422752. PMID 28512424.
- ↑ Evans, D G. R (2000). "Neurofibromatosis type 2". Journal of Medical Genetics. 37 (12): 897–904. doi:10.1136/jmg.37.12.897. ISSN 1468-6244.
- ↑ 6.0 6.1 Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007). "Fibromuscular dysplasia". Orphanet J Rare Dis. 2: 28. doi:10.1186/1750-1172-2-28. PMC 1899482. PMID 17555581.
- ↑ Gazit Y, Jacob G, Grahame R (2016). "Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder". Rambam Maimonides Med J. 7 (4). doi:10.5041/RMMJ.10261. PMC 5101008. PMID 27824552.
- ↑ Michet CJ, Matteson EL (2008). "Polymyalgia rheumatica". BMJ. 336 (7647): 765–9. doi:10.1136/bmj.39514.653588.80. PMC 2287267. PMID 18390527.
- ↑ Baker KR, Rice L (2012). "The amyloidoses: clinical features, diagnosis and treatment". Methodist Debakey Cardiovasc J. 8 (3): 3–7. PMC 3487569. PMID 23227278.
- ↑ Howard T, Ahmad K, Swanson JA, Misra S (2014). "Polyarteritis nodosa". Tech Vasc Interv Radiol. 17 (4): 247–51. doi:10.1053/j.tvir.2014.11.005. PMC 4363102. PMID 25770638.
- ↑ Sharma A, Sharma K (September 2013). "Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis". J Clin Exp Hepatol. 3 (3): 204–12. doi:10.1016/j.jceh.2013.06.001. PMC 4216827. PMID 25755502.
- ↑ Takahashi K, Oharaseki T, Yokouchi Y (2011). "Pathogenesis of Kawasaki disease". Clin Exp Immunol. 164 Suppl 1: 20–2. doi:10.1111/j.1365-2249.2011.04361.x. PMC 3095860. PMID 21447126.
- ↑ Heegaard ED, Brown KE (2002). "Human parvovirus B19". Clin Microbiol Rev. 15 (3): 485–505. PMC 118081. PMID 12097253.
- ↑ Basetti S, Hodgson J, Rawson TM, Majeed A (2017). "Scarlet fever: a guide for general practitioners". London J Prim Care (Abingdon). 9 (5): 77–79. doi:10.1080/17571472.2017.1365677. PMC 5649319. PMID 29081840.
- ↑ Vostral SL (2011). "Rely and Toxic Shock Syndrome: a technological health crisis". Yale J Biol Med. 84 (4): 447–59. PMC 3238331. PMID 22180682.
- ↑ Balfour HH, Dunmire SK, Hogquist KA (2015). "Infectious mononucleosis". Clin Transl Immunology. 4 (2): e33. doi:10.1038/cti.2015.1. PMC 4346501. PMID 25774295.
- ↑ Levett PN (April 2001). "Leptospirosis". Clin. Microbiol. Rev. 14 (2): 296–326. doi:10.1128/CMR.14.2.296-326.2001. PMC 88975. PMID 11292640.
- ↑ Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T (2012). "Lyme disease: review". Arch Med Sci. 8 (6): 978–82. doi:10.5114/aoms.2012.30948. PMC 3542482. PMID 23319969.
- ↑ White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM (2012). "Measles, mumps, and rubella". Clin Obstet Gynecol. 55 (2): 550–9. doi:10.1097/GRF.0b013e31824df256. PMC 3334858. PMID 22510638.
- ↑ Walker DH (1989). "Rocky Mountain spotted fever: a disease in need of microbiological concern". Clin Microbiol Rev. 2 (3): 227–40. PMC 358117. PMID 2504480.
- ↑ Mishra AK, Yadav P, Mishra A (2016). "A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates". Open Microbiol J. 10: 150–9. doi:10.2174/1874285801610010150. PMC 5012080. PMID 27651848.
- ↑ Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E; et al. (2016). "Toxic epidermal necrolysis". F1000Res. 5. doi:10.12688/f1000research.7574.1. PMC 4879934. PMID 27239294.
- ↑ MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, McGovern E (June 1993). "Atrial myxoma: national incidence, diagnosis and surgical management". Ir J Med Sci. 162 (6): 223–6. PMID 8407260.
- ↑ Avci G, Akoz T, Gul AE (2009). "Cutaneous cholesterol embolization". J Dermatol Case Rep. 3 (2): 27–9. doi:10.3315/jdcr.2009.1031. PMC 3157794. PMID 21886725.
- ↑ Chao, Christine (2009). "Segmental Arterial Mediolysis". Seminars in Interventional Radiology. 26 (03): 224–232. doi:10.1055/s-0029-1225666. ISSN 0739-9529.
- ↑ Chaturvedi S, McCrae KR (2015). "The antiphospholipid syndrome: still an enigma". Hematology Am Soc Hematol Educ Program. 2015: 53–60. doi:10.1182/asheducation-2015.1.53. PMC 4877624. PMID 26637701.
- ↑ Espinosa M, Gottlieb BS (July 2012). "Juvenile idiopathic arthritis". Pediatr Rev. 33 (7): 303–13. doi:10.1542/pir.33-7-303. PMID 22753788.
- ↑ Chung SA, Seo P (2010). "Microscopic polyangiitis". Rheum Dis Clin North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
- ↑ Kubaisi B, Abu Samra K, Foster CS (2016). "Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations". Intractable Rare Dis Res. 5 (2): 61–9. doi:10.5582/irdr.2016.01014. PMC 4869584. PMID 27195187.
- ↑ Keogh KA, Specks U (April 2006). "Churg-Strauss syndrome". Semin Respir Crit Care Med. 27 (2): 148–57. doi:10.1055/s-2006-939518. PMID 16612766.
- ↑ Keasberry J, Frazier J, Isbel NM, Van Eps CL, Oliver K, Mudge DW (2013). "Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report". J Med Case Rep. 7: 20. doi:10.1186/1752-1947-7-20. PMC 3565908. PMID 23316942.
- ↑ McAdoo SP, Pusey CD (July 2017). "Anti-Glomerular Basement Membrane Disease". Clin J Am Soc Nephrol. 12 (7): 1162–1172. doi:10.2215/CJN.01380217. PMID 28515156.
- ↑ Ferri C, Mascia MT (January 2006). "Cryoglobulinemic vasculitis". Curr Opin Rheumatol. 18 (1): 54–63. PMID 16344620.